Clinical Utility of AFP-L3% Measurement in North American Patients with HCV-Related Cirrhosis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-07-07

AUTHORS

Richard K Sterling, Lennox Jeffers, Fredric Gordon, Morris Sherman, Alan P Venook, K Rajender Reddy, Shinji Satomura, Myron E Schwartz

ABSTRACT

BACKGROUND AND AIMS: Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3%) has been reported to be useful in the early detection of hepatocellular carcinoma (HCC) in Japan. The aim of this prospective study was to compare the clinical utility of AFP-L3% with that of total AFP in North American patients. METHODS: Patients with chronic hepatitis (CH) C virus-related cirrhosis from 7 clinical sites were prospectively followed every 3-6 months for 2 yr. RESULTS: Of the 372 patients evaluated, 40 had hepatitis C virus-related HCC at entry and 332 entered the prospective trial. Of the latter, 34 developed HCC and 298 remained free of HCC. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for AFP were 60.8%, 71.1%, 34.4%, and 88.0% with a cutoff of 20 ng/mL and 21.6%, 98.7%, 80.0%, and 83.5% with a cutoff of 200 ng/mL, compared to 36.5%, 91.6%, 51.9%, and 85.3% for AFP-L3% with a cutoff of 10%. In those with an elevated AFP (20-200 ng/mL), AFP-L3% had a specificity of 86.6% and an NPV of 80.7%. Multivariate analysis identified AFP, AFP-L3%, and age as independent predictors of HCC. Elevated AFP-L3% was associated with a lower cumulative HCC-free rate at 2 yr (58.9%) than was AFP (82.0%, P= 0.01). CONCLUSIONS: The incidence of HCC was significantly higher in patients with elevated AFP-L3% than in those with elevated AFP. The high specificity of AFP-L3% persisted among patients with elevated AFP (20-200 ng/mL) and suggests that AFP-L3% has clinical utility in HCV patients with AFP of 20-200 ng/mL. More... »

PAGES

ajg2007428

Identifiers

URI

http://scigraph.springernature.com/pub.10.1111/j.1572-0241.2007.01405.x

DOI

http://dx.doi.org/10.1111/j.1572-0241.2007.01405.x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1012934433

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17617202


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Canada", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis C, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Cirrhosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plant Lectins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "alpha-Fetoproteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Virginia Commonwealth University Health Systems, Richmond, Virginia", 
          "id": "http://www.grid.ac/institutes/grid.224260.0", 
          "name": [
            "Virginia Commonwealth University Health Systems, Richmond, Virginia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sterling", 
        "givenName": "Richard K", 
        "id": "sg:person.01337112464.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337112464.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Miami School of Medicine/Miami VA Medical Center, Miami, Florida", 
          "id": "http://www.grid.ac/institutes/grid.26790.3a", 
          "name": [
            "University of Miami School of Medicine/Miami VA Medical Center, Miami, Florida"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeffers", 
        "givenName": "Lennox", 
        "id": "sg:person.0613162445.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613162445.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lahey Clinic Medical Center, Burlington, Massachusetts", 
          "id": "http://www.grid.ac/institutes/grid.415731.5", 
          "name": [
            "Lahey Clinic Medical Center, Burlington, Massachusetts"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gordon", 
        "givenName": "Fredric", 
        "id": "sg:person.07430360637.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07430360637.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Toronto General Hospital, Toronto, Ontario, Canada", 
          "id": "http://www.grid.ac/institutes/grid.417184.f", 
          "name": [
            "Toronto General Hospital, Toronto, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sherman", 
        "givenName": "Morris", 
        "id": "sg:person.01206303405.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206303405.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California\u2014San Francisco Medical Center, San Francisco, California", 
          "id": "http://www.grid.ac/institutes/grid.413077.6", 
          "name": [
            "University of California\u2014San Francisco Medical Center, San Francisco, California"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Venook", 
        "givenName": "Alan P", 
        "id": "sg:person.01347652015.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347652015.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania Health System, Philadelphia, Pennsylvania", 
          "id": "http://www.grid.ac/institutes/grid.412701.1", 
          "name": [
            "University of Pennsylvania Health System, Philadelphia, Pennsylvania"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reddy", 
        "givenName": "K Rajender", 
        "id": "sg:person.012704034572.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012704034572.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wako Pure Chemical Industries, Ltd., Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.419841.1", 
          "name": [
            "Wako Pure Chemical Industries, Ltd., Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Satomura", 
        "givenName": "Shinji", 
        "id": "sg:person.01010774023.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010774023.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mount Sinai School of Medicine, New York, New York", 
          "id": "http://www.grid.ac/institutes/grid.59734.3c", 
          "name": [
            "Mount Sinai School of Medicine, New York, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schwartz", 
        "givenName": "Myron E", 
        "id": "sg:person.01101462313.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101462313.97"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1111/j.1572-0241.1999.01378.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033879569", 
          "https://doi.org/10.1111/j.1572-0241.1999.01378.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2006.00681.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043691538", 
          "https://doi.org/10.1111/j.1572-0241.2006.00681.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.1998.00703.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027245911", 
          "https://doi.org/10.1111/j.1572-0241.1998.00703.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2006.00679.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051689732", 
          "https://doi.org/10.1111/j.1572-0241.2006.00679.x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-07-07", 
    "datePublishedReg": "2007-07-07", 
    "description": "BACKGROUND AND AIMS: Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3%) has been reported to be useful in the early detection of hepatocellular carcinoma (HCC) in Japan. The aim of this prospective study was to compare the clinical utility of AFP-L3% with that of total AFP in North American patients.\nMETHODS: Patients with chronic hepatitis (CH) C virus-related cirrhosis from 7 clinical sites were prospectively followed every 3-6 months for 2 yr.\nRESULTS: Of the 372 patients evaluated, 40 had hepatitis C virus-related HCC at entry and 332 entered the prospective trial. Of the latter, 34 developed HCC and 298 remained free of HCC. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for AFP were 60.8%, 71.1%, 34.4%, and 88.0% with a cutoff of 20 ng/mL and 21.6%, 98.7%, 80.0%, and 83.5% with a cutoff of 200 ng/mL, compared to 36.5%, 91.6%, 51.9%, and 85.3% for AFP-L3% with a cutoff of 10%. In those with an elevated AFP (20-200 ng/mL), AFP-L3% had a specificity of 86.6% and an NPV of 80.7%. Multivariate analysis identified AFP, AFP-L3%, and age as independent predictors of HCC. Elevated AFP-L3% was associated with a lower cumulative HCC-free rate at 2 yr (58.9%) than was AFP (82.0%, P= 0.01).\nCONCLUSIONS: The incidence of HCC was significantly higher in patients with elevated AFP-L3% than in those with elevated AFP. The high specificity of AFP-L3% persisted among patients with elevated AFP (20-200 ng/mL) and suggests that AFP-L3% has clinical utility in HCV patients with AFP of 20-200 ng/mL.", 
    "genre": "article", 
    "id": "sg:pub.10.1111/j.1572-0241.2007.01405.x", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1412991", 
        "issn": [
          "0002-9270", 
          "1572-0241"
        ], 
        "name": "The American Journal of Gastroenterology", 
        "publisher": "Wolters Kluwer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "102"
      }
    ], 
    "keywords": [
      "negative predictive value", 
      "North American patients", 
      "hepatocellular carcinoma", 
      "elevated AFP", 
      "AFP-L3", 
      "positive predictive value", 
      "clinical utility", 
      "American patients", 
      "hepatitis C virus-related cirrhosis", 
      "predictive value", 
      "hepatitis C virus-related hepatocellular carcinoma", 
      "C virus-related hepatocellular carcinoma", 
      "C virus-related cirrhosis", 
      "Lens culinaris agglutinin-reactive fraction", 
      "incidence of HCC", 
      "virus-related hepatocellular carcinoma", 
      "virus-related cirrhosis", 
      "agglutinin-reactive fraction", 
      "HCV patients", 
      "prospective trial", 
      "independent predictors", 
      "prospective study", 
      "total AFP", 
      "patients", 
      "alpha-fetoprotein", 
      "multivariate analysis", 
      "clinical sites", 
      "early detection", 
      "AFP", 
      "cirrhosis", 
      "high specificity", 
      "cutoff", 
      "specificity", 
      "HCV", 
      "carcinoma", 
      "incidence", 
      "trials", 
      "months", 
      "age", 
      "yr", 
      "predictors", 
      "utility", 
      "aim", 
      "study", 
      "background", 
      "sensitivity", 
      "rate", 
      "entry", 
      "values", 
      "sites", 
      "detection", 
      "fraction", 
      "Japan", 
      "analysis", 
      "measurements"
    ], 
    "name": "Clinical Utility of AFP-L3% Measurement in North American Patients with HCV-Related Cirrhosis", 
    "pagination": "ajg2007428", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1012934433"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1111/j.1572-0241.2007.01405.x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17617202"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1111/j.1572-0241.2007.01405.x", 
      "https://app.dimensions.ai/details/publication/pub.1012934433"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_449.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1111/j.1572-0241.2007.01405.x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1111/j.1572-0241.2007.01405.x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1111/j.1572-0241.2007.01405.x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1111/j.1572-0241.2007.01405.x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1111/j.1572-0241.2007.01405.x'


 

This table displays all metadata directly associated to this object as RDF triples.

263 TRIPLES      22 PREDICATES      100 URIs      88 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1111/j.1572-0241.2007.01405.x schema:about N2a87cd95f9d6416eb1ba830cd24d82ca
2 N393f4c364f1647789fea9c443f7ec5b2
3 N3e3787aff5ca4442a36114754881d25d
4 N726f1889b09d4491a7f45a98e3e9b453
5 N7479db87677243e7aa6fab02bf8cba05
6 N78e1e0f5674042c2b0ea8c96224c08dc
7 N8aed2b2db12d4ef4b66ef1327c2b2631
8 N8c9262a152cf4250bfab1760b57d82a4
9 Nb3fad2ef1e0544f19ec27e6d418ca1d4
10 Nbe063fc2f08541cb9f145642f0470945
11 Nd1d8a79669ca46e29ef3189aa42e5a49
12 Nd6bb46cfbe1947f5a49358d22e6b4f45
13 Nec627090b1574a5680c3e2ba6612858d
14 Nf893b95bf45b41229f00b422974f9fc3
15 Nfc0c7ea071894df78e06d1fa704e22d5
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N2a21abbec47244e097cdc8f69c9eac46
19 schema:citation sg:pub.10.1111/j.1572-0241.1998.00703.x
20 sg:pub.10.1111/j.1572-0241.1999.01378.x
21 sg:pub.10.1111/j.1572-0241.2006.00679.x
22 sg:pub.10.1111/j.1572-0241.2006.00681.x
23 schema:datePublished 2007-07-07
24 schema:datePublishedReg 2007-07-07
25 schema:description BACKGROUND AND AIMS: Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3%) has been reported to be useful in the early detection of hepatocellular carcinoma (HCC) in Japan. The aim of this prospective study was to compare the clinical utility of AFP-L3% with that of total AFP in North American patients. METHODS: Patients with chronic hepatitis (CH) C virus-related cirrhosis from 7 clinical sites were prospectively followed every 3-6 months for 2 yr. RESULTS: Of the 372 patients evaluated, 40 had hepatitis C virus-related HCC at entry and 332 entered the prospective trial. Of the latter, 34 developed HCC and 298 remained free of HCC. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for AFP were 60.8%, 71.1%, 34.4%, and 88.0% with a cutoff of 20 ng/mL and 21.6%, 98.7%, 80.0%, and 83.5% with a cutoff of 200 ng/mL, compared to 36.5%, 91.6%, 51.9%, and 85.3% for AFP-L3% with a cutoff of 10%. In those with an elevated AFP (20-200 ng/mL), AFP-L3% had a specificity of 86.6% and an NPV of 80.7%. Multivariate analysis identified AFP, AFP-L3%, and age as independent predictors of HCC. Elevated AFP-L3% was associated with a lower cumulative HCC-free rate at 2 yr (58.9%) than was AFP (82.0%, P= 0.01). CONCLUSIONS: The incidence of HCC was significantly higher in patients with elevated AFP-L3% than in those with elevated AFP. The high specificity of AFP-L3% persisted among patients with elevated AFP (20-200 ng/mL) and suggests that AFP-L3% has clinical utility in HCV patients with AFP of 20-200 ng/mL.
26 schema:genre article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N3635228575634e7ba180af1e9d24b685
30 Na7abf00a527c43f4b4607b4efa13748e
31 sg:journal.1412991
32 schema:keywords AFP
33 AFP-L3
34 American patients
35 C virus-related cirrhosis
36 C virus-related hepatocellular carcinoma
37 HCV
38 HCV patients
39 Japan
40 Lens culinaris agglutinin-reactive fraction
41 North American patients
42 age
43 agglutinin-reactive fraction
44 aim
45 alpha-fetoprotein
46 analysis
47 background
48 carcinoma
49 cirrhosis
50 clinical sites
51 clinical utility
52 cutoff
53 detection
54 early detection
55 elevated AFP
56 entry
57 fraction
58 hepatitis C virus-related cirrhosis
59 hepatitis C virus-related hepatocellular carcinoma
60 hepatocellular carcinoma
61 high specificity
62 incidence
63 incidence of HCC
64 independent predictors
65 measurements
66 months
67 multivariate analysis
68 negative predictive value
69 patients
70 positive predictive value
71 predictive value
72 predictors
73 prospective study
74 prospective trial
75 rate
76 sensitivity
77 sites
78 specificity
79 study
80 total AFP
81 trials
82 utility
83 values
84 virus-related cirrhosis
85 virus-related hepatocellular carcinoma
86 yr
87 schema:name Clinical Utility of AFP-L3% Measurement in North American Patients with HCV-Related Cirrhosis
88 schema:pagination ajg2007428
89 schema:productId N2428726cbc4e41808e488889255f75c4
90 N2ce1359ec66b4857b7ced6580ac89ec8
91 N72bd11c279634b65aaca0b7a545e34d8
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012934433
93 https://doi.org/10.1111/j.1572-0241.2007.01405.x
94 schema:sdDatePublished 2022-05-20T07:24
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher Nce908ed8a6eb46f8bf717e4751f32578
97 schema:url https://doi.org/10.1111/j.1572-0241.2007.01405.x
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N0d7cb78814614086bd60b740e5e2af59 rdf:first sg:person.07430360637.03
102 rdf:rest N13c35542d8df482593e4b1cd75d1f39c
103 N13c35542d8df482593e4b1cd75d1f39c rdf:first sg:person.01206303405.31
104 rdf:rest Nb27733096e874908842fa36e1ac06eb3
105 N2428726cbc4e41808e488889255f75c4 schema:name doi
106 schema:value 10.1111/j.1572-0241.2007.01405.x
107 rdf:type schema:PropertyValue
108 N2a21abbec47244e097cdc8f69c9eac46 rdf:first sg:person.01337112464.07
109 rdf:rest Ncad25cbd099047778690e0e34037de34
110 N2a87cd95f9d6416eb1ba830cd24d82ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Adult
112 rdf:type schema:DefinedTerm
113 N2ce1359ec66b4857b7ced6580ac89ec8 schema:name dimensions_id
114 schema:value pub.1012934433
115 rdf:type schema:PropertyValue
116 N3635228575634e7ba180af1e9d24b685 schema:volumeNumber 102
117 rdf:type schema:PublicationVolume
118 N393f4c364f1647789fea9c443f7ec5b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Liver Neoplasms
120 rdf:type schema:DefinedTerm
121 N3e3787aff5ca4442a36114754881d25d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Liver Cirrhosis
123 rdf:type schema:DefinedTerm
124 N6a00ca9613554b9db27979ea73eca6d9 rdf:first sg:person.01101462313.97
125 rdf:rest rdf:nil
126 N726f1889b09d4491a7f45a98e3e9b453 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Carcinoma, Hepatocellular
128 rdf:type schema:DefinedTerm
129 N72bd11c279634b65aaca0b7a545e34d8 schema:name pubmed_id
130 schema:value 17617202
131 rdf:type schema:PropertyValue
132 N7479db87677243e7aa6fab02bf8cba05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Cohort Studies
134 rdf:type schema:DefinedTerm
135 N78e1e0f5674042c2b0ea8c96224c08dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Hepatitis C, Chronic
137 rdf:type schema:DefinedTerm
138 N8aed2b2db12d4ef4b66ef1327c2b2631 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Plant Lectins
140 rdf:type schema:DefinedTerm
141 N8c9262a152cf4250bfab1760b57d82a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Predictive Value of Tests
143 rdf:type schema:DefinedTerm
144 N95fd1a9e3b6a4edc9a45eb95512a3cc3 rdf:first sg:person.01010774023.01
145 rdf:rest N6a00ca9613554b9db27979ea73eca6d9
146 Na7abf00a527c43f4b4607b4efa13748e schema:issueNumber 10
147 rdf:type schema:PublicationIssue
148 Nb27733096e874908842fa36e1ac06eb3 rdf:first sg:person.01347652015.55
149 rdf:rest Ne9637399c41e4e228bbb4cfb21ab409b
150 Nb3fad2ef1e0544f19ec27e6d418ca1d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Aged
152 rdf:type schema:DefinedTerm
153 Nbe063fc2f08541cb9f145642f0470945 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name alpha-Fetoproteins
155 rdf:type schema:DefinedTerm
156 Ncad25cbd099047778690e0e34037de34 rdf:first sg:person.0613162445.10
157 rdf:rest N0d7cb78814614086bd60b740e5e2af59
158 Nce908ed8a6eb46f8bf717e4751f32578 schema:name Springer Nature - SN SciGraph project
159 rdf:type schema:Organization
160 Nd1d8a79669ca46e29ef3189aa42e5a49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name United States
162 rdf:type schema:DefinedTerm
163 Nd6bb46cfbe1947f5a49358d22e6b4f45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Humans
165 rdf:type schema:DefinedTerm
166 Ne9637399c41e4e228bbb4cfb21ab409b rdf:first sg:person.012704034572.98
167 rdf:rest N95fd1a9e3b6a4edc9a45eb95512a3cc3
168 Nec627090b1574a5680c3e2ba6612858d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Canada
170 rdf:type schema:DefinedTerm
171 Nf893b95bf45b41229f00b422974f9fc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Double-Blind Method
173 rdf:type schema:DefinedTerm
174 Nfc0c7ea071894df78e06d1fa704e22d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Middle Aged
176 rdf:type schema:DefinedTerm
177 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
178 schema:name Medical and Health Sciences
179 rdf:type schema:DefinedTerm
180 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
181 schema:name Clinical Sciences
182 rdf:type schema:DefinedTerm
183 sg:journal.1412991 schema:issn 0002-9270
184 1572-0241
185 schema:name The American Journal of Gastroenterology
186 schema:publisher Wolters Kluwer
187 rdf:type schema:Periodical
188 sg:person.01010774023.01 schema:affiliation grid-institutes:grid.419841.1
189 schema:familyName Satomura
190 schema:givenName Shinji
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010774023.01
192 rdf:type schema:Person
193 sg:person.01101462313.97 schema:affiliation grid-institutes:grid.59734.3c
194 schema:familyName Schwartz
195 schema:givenName Myron E
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101462313.97
197 rdf:type schema:Person
198 sg:person.01206303405.31 schema:affiliation grid-institutes:grid.417184.f
199 schema:familyName Sherman
200 schema:givenName Morris
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206303405.31
202 rdf:type schema:Person
203 sg:person.012704034572.98 schema:affiliation grid-institutes:grid.412701.1
204 schema:familyName Reddy
205 schema:givenName K Rajender
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012704034572.98
207 rdf:type schema:Person
208 sg:person.01337112464.07 schema:affiliation grid-institutes:grid.224260.0
209 schema:familyName Sterling
210 schema:givenName Richard K
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337112464.07
212 rdf:type schema:Person
213 sg:person.01347652015.55 schema:affiliation grid-institutes:grid.413077.6
214 schema:familyName Venook
215 schema:givenName Alan P
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347652015.55
217 rdf:type schema:Person
218 sg:person.0613162445.10 schema:affiliation grid-institutes:grid.26790.3a
219 schema:familyName Jeffers
220 schema:givenName Lennox
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613162445.10
222 rdf:type schema:Person
223 sg:person.07430360637.03 schema:affiliation grid-institutes:grid.415731.5
224 schema:familyName Gordon
225 schema:givenName Fredric
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07430360637.03
227 rdf:type schema:Person
228 sg:pub.10.1111/j.1572-0241.1998.00703.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027245911
229 https://doi.org/10.1111/j.1572-0241.1998.00703.x
230 rdf:type schema:CreativeWork
231 sg:pub.10.1111/j.1572-0241.1999.01378.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033879569
232 https://doi.org/10.1111/j.1572-0241.1999.01378.x
233 rdf:type schema:CreativeWork
234 sg:pub.10.1111/j.1572-0241.2006.00679.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051689732
235 https://doi.org/10.1111/j.1572-0241.2006.00679.x
236 rdf:type schema:CreativeWork
237 sg:pub.10.1111/j.1572-0241.2006.00681.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043691538
238 https://doi.org/10.1111/j.1572-0241.2006.00681.x
239 rdf:type schema:CreativeWork
240 grid-institutes:grid.224260.0 schema:alternateName Virginia Commonwealth University Health Systems, Richmond, Virginia
241 schema:name Virginia Commonwealth University Health Systems, Richmond, Virginia
242 rdf:type schema:Organization
243 grid-institutes:grid.26790.3a schema:alternateName University of Miami School of Medicine/Miami VA Medical Center, Miami, Florida
244 schema:name University of Miami School of Medicine/Miami VA Medical Center, Miami, Florida
245 rdf:type schema:Organization
246 grid-institutes:grid.412701.1 schema:alternateName University of Pennsylvania Health System, Philadelphia, Pennsylvania
247 schema:name University of Pennsylvania Health System, Philadelphia, Pennsylvania
248 rdf:type schema:Organization
249 grid-institutes:grid.413077.6 schema:alternateName University of California—San Francisco Medical Center, San Francisco, California
250 schema:name University of California—San Francisco Medical Center, San Francisco, California
251 rdf:type schema:Organization
252 grid-institutes:grid.415731.5 schema:alternateName Lahey Clinic Medical Center, Burlington, Massachusetts
253 schema:name Lahey Clinic Medical Center, Burlington, Massachusetts
254 rdf:type schema:Organization
255 grid-institutes:grid.417184.f schema:alternateName Toronto General Hospital, Toronto, Ontario, Canada
256 schema:name Toronto General Hospital, Toronto, Ontario, Canada
257 rdf:type schema:Organization
258 grid-institutes:grid.419841.1 schema:alternateName Wako Pure Chemical Industries, Ltd., Osaka, Japan
259 schema:name Wako Pure Chemical Industries, Ltd., Osaka, Japan
260 rdf:type schema:Organization
261 grid-institutes:grid.59734.3c schema:alternateName Mount Sinai School of Medicine, New York, New York
262 schema:name Mount Sinai School of Medicine, New York, New York
263 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...